Elbatreek, M., Shah, S., Tang, W. H., Brown, M., Hazen, S., Li, X., Goodchild, T., Sharp, T., Lefer, D. (2025). Abstract 4359480: GLP-1 Agonist Therapy Attenuates Circulating Gut-Derived Trimethylamine N-Oxide (TMAO) and Improves Cardiac Function and Exercise Performance in Cardiometabolic HFpEF. Circulation. https://doi.org/10.1161/circ.152.suppl_3.4359480